Annie Yoshiyama
Chief Accounting Officer
Allogene Therapeutics, Inc. (ALLO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Annie Yoshiyama
Annie Yoshiyama is recorded as Chief Accounting Officer at Allogene Therapeutics, Inc. (ALLO). Allogene Therapeutics, Inc. reported in an 8-K filed June 10, 2024 that Annie Yoshiyama was appointed principal accounting officer, effective June 5, 2024.
“On June 5, 2024, the Board of Directors of Allogene Therapeutics, Inc. (the "Company") appointed Annie Yoshiyama, the Company's current Senior Vice President and Corporate Controller, as the Company's principal accounting officer, effective immediately, replacing Geoffrey Parker in such capacity.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-06-05–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Allogene Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Zachary Roberts, M.D., Ph.D. CEO, Board Member
- Geoffrey Parker CFO
- Tim Moore CTO
- Timothy Moore CTO
- Elizabeth Barrett Board Member
- Stephen Mayo, Ph.D. Board Member
- Vicki Sato, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.